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CHAPK is the N-terminal cysteine, histidine-dependent amidohydrolase/
peptidase domain (CHAP domain) of the Staphylococcus aureus bacteriophage
K endolysin LysK. It is formed from the first 165 residues of LysK and functions
by cleaving specific peptidoglycan peptide bonds, causing bacterial lysis. CHAPK
can lyse S. aureus when applied exogenously, making it a good candidate for the
treatment of multidrug-resistant Staphylococcus aureus infections. Here, the
crystallization of CHAPK and the collection of native and derivative data to high
resolution, which allowed structure solution, are reported. The structure may
help to elucidate the mechanism of action and in the design of chimeric proteins
or mutants with improved antibacterial activity.
1. Introduction
Staphylococci are Gram-positive bacteria that can cause disease in
both humans and animals. In recent years, they have become a serious
concern owing to their ability to acquire genes associated with anti-
biotic resistance (Holden et al., 2013). Biofilm formation has been
reported to significantly contribute to this problem by causing up to a
1000-fold increase in bacterial antibiotic resistance (Olson et al.,
2002). This is an important point in relation to staphylococcal
infections, because they are the main cause of nosocomial and
medical device-related infections, which are generally biofilm-
associated (Otto, 2008).
It is known that bacteriophages, such as the myovirus bacterio-
phage K (Rees & Fry, 1981; O’Flaherty, Ross et al., 2005), and their
endolysins are highly effective at lysing Staphylococcus aureus,
including methicillin-resistant strains (MRSA; Ralston et al., 1955;
Sonstein et al., 1971; O’Flaherty, Coffey et al., 2005; Fenton, Ross et
al., 2011). Bacteriophage-encoded endolysins are peptidoglycan
hydrolases used by the phages to degrade the bacterial cell wall in the
late stages of the phage replication cycle, allowing their progeny to
escape from the cell (Loessner, 2005). When applied exogenously to
Gram-positive pathogens, endolysins can degrade the peptidoglycan
and cause ‘lysis from without’ or exolysis (Ralston & McIvor, 1967).
These enzymes are highly specific owing to the high level of diversity
in the peptidoglycan structure in Gram-positive bacteria at both the
genera and species level. Also of note is the fact that no bacterial
strains resistant to their phage endolysins have yet been found
(Loeffler et al., 2001; Schuch et al., 2002).
LysK, the 495 amino-acid endolysin from bacteriophage K, has
been shown to kill a wide range of staphylococci, including MRSA
(O’Flaherty, Coffey et al., 2005). This enzyme acts synergistically with
lysostaphin, an antistaphylococcal bacteriocin synthesized by
S. simulans (Becker et al., 2008), although it may also be used in
isolation. LysK contains three domains: an N-terminal cysteine,
histidine-dependent amidohydrolase/peptidase domain (CHAP;
residues 35–160), a central amidase domain (amidase 2; residues
197–346) and a C-terminal SH3b cell-wall-binding domain (residues
412–481). The amidase 2 domain cleaves peptidoglycan between N-
acetylmuramic acid and l-alanine of the stem peptide, while the
CHAP domain has been reported to cleave between d-alanine and
the first glycine of the pentaglycine cross-bridge (Fig. 1; Becker et al.,
2009). CHAPK is the only domain necessary for exolysis of S. aureus
cells and a truncated enzyme containing the first 165 amino acids of
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LysK showed an activity twofold higher than the native protein
(Horgan et al., 2009). The reason for this may be that the SH3b
domain is inhibitory when not bound to the cell wall, so removing it
may activate the enzyme (Low et al., 2005). CHAPK has also been
demonstrated to prevent and rapidly eliminate staphylococcal
biofilms in vitro (Fenton et al., 2013).
Here, we report the crystallization of CHAPK, native X-ray
diffraction data collected to 1.8 A˚ resolution and successful structure
solution using data collected from a mercury derivative.
2. Methods
Residues 1–165 of LysK endolysin, encoding the entire CHAP
domain, were previously cloned into the pQE60 plasmid and trans-
formed into Escherichia coli XL1-Blue (Qiagen, Venlo, Netherlands;
Horgan et al., 2009). The C-terminal His tag was avoided by including
a stop codon; the protein product of this construct is called CHAPK.
Expression and purification of CHAPK by cation-exchange chroma-
tography were performed as described by Fenton, Cooney et al.
(2011). The purified protein was desalted and concentrated by a
buffer exchange with 25 mM Tris–HCl pH 7 in an Amicon Ultra
centrifugal filter with a molecular-weight cutoff of 10 kDa (Millipore,
Billerica, Massachusetts, USA). The concentration of the protein was
measured using a Pierce BCA Protein Assay Kit (Thermo Scientific,
Rockford, Illinois, USA). The protein was stored in aliquots at 193 K;
4–10 mg of purified protein per litre of bacterial culture was obtained.
The integrity and purity of the protein were checked using poly-
acrylamide gel electrophoresis following Laemmli’s protocol
(Laemmli, 1970). The concentration of acrylamide in the resolving gel
was 12.5%(w/v). Before performing crystallization trials, the protein
was further concentrated using the same centrifugal filters as
mentioned previously without a buffer change.
Initial crystallization screening was carried out using sitting-drop
vapour diffusion at 294 K, employing different commercial kits,
Wizard I and II (Emerald Biosystems, Bainbridge Island,
Washington, USA), Morpheus (Molecular Dimensions, Newmarket,
Suffolk, England) and JBScreen Basic (Jena Bioscience, Jena,
Germany), and a Genesis RSP 150 workstation (Tecan, Ma¨nnedorf,
Switzerland) with MRC 96-well sitting-drop crystallization plates
(Molecular Dimensions, Newmarket, Suffolk, England). The reser-
voir contained 50 ml reservoir solution and drops were formed by
mixing 0.2 ml protein solution with 0.2 ml reservoir solution. The
conditions that gave the most promising results were scaled up and
optimized to fine-tune the precipitant concentration, protein
concentration and pH. Sitting-drop vapour-diffusion CompactClover
4-Chamber plates (Jena Bioscience, Jena, Germany) were used for
optimization and the reservoir contained 0.15 ml reservoir solution,
with drops made up by mixing 2 ml protein solution with 2 ml reservoir
solution.
The crystal used for native data collection was from a drop for
which the reservoir solution consisted of 22%(w/v) polyethylene
glycol (PEG) 8000, 0.1M 2-(N-morpholino)ethanesulfonic acid
(MES)–NaOH pH 6.5. For derivatization, a drop for which the
reservoir solution consisted of 22%(w/v) PEG 8000, 0.1M 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)–NaOH pH
6.5 was used. A few grains of solid methylmercury chloride were
transferred into the reservoir and mixed by pipetting the reservoir up
and down; 0.5 ml of this modified reservoir was then added to the
protein drop and the experiment was re-sealed.
Crystals were cryoprotected by sequential soaking in 5, 10, 15 and
20% glycerol in crystallization solution in the same drop that they
were grown in, removing and replacing about 80% of the drop
volume at each step (20–30 s per step). For the derivative, this
procedure thus effectively involved a quick and probably incomplete
back-soak. Crystals were then vitrified by rapid immersion in liquid
nitrogen. Data were collected with crystals maintained at 100 K.
iMosflm (Battye et al., 2011) was used for indexing and integration
of the native data and POINTLESS, SCALA and C-TRUNCATE
from the CCP4 suite (Winn et al., 2011) were used for scaling and
merging (Evans, 2011). Derivative data were integrated using xia2
(Winter et al., 2013), which incorporates XDS (Kabsch, 2010) and
AIMLESS (Evans & Murshudov, 2013). Matthews coefficient deter-
mination was performed using MATTHEWS_COEF (Matthews,
1968). Phase determination and refinement were performed using
autoSHARP (Vonrhein et al., 2007). This procedure includes heavy-
atom site location by SHELXC/D (Sheldrick, 2008), phase refine-
ment with SHARP (Bricogne et al., 2003), which found additional
sites and rejected sites, solvent flattening and histogram matching
with SOLOMON (Abrahams & Leslie, 1996), automated model
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Figure 1
Scheme of the S. aureus peptidoglycan structure. Bacteriophage K endolysin (LysK) cleavage sites are indicated. The CHAP domain cleaves at the sites indicated with
arrows, while the amidase 2 domain acts on the bonds indicated with asterisks. GlcNAc stands for N-acetylglucosamine and MurNAc for N-acetylmuramic acid.
building with ARP/wARP (Langer et al., 2008) and refinement with
REFMAC5 (Murshudov et al., 2011).
3. Results and discussion
The purity of the CHAPK lysin was verified by denaturing gel elec-
trophoresis, showing a band at approximately 17 kDa (Fig. 2), which
is consistent with the expected molecular weight of the protein,
18.6 kDa. Slight amounts of impurities could also be observed. The
protein was concentrated to 32 mg ml1 and a wide range of crys-
tallization conditions (288 drops) were screened by vapour diffusion
in small-volume sitting drops. Although no crystals were obtained,
some drops containing PEG 8000 at pH 6.5 and 10.5 contained
crystalline-looking precipitates. After fine-screening of buffer
composition, pH and precipitant concentration in larger drops (24
drops in total), large plate-shaped crystals were obtained at pH 6.5
(Fig. 3); these were used for native data collection. Crystals of the
same shape were obtained at pH 7.5 and were used for derivatization
with methylmercury chloride. The crystals reached maximal dimen-
sions of around 1.0  0.5  0.05 mm (Fig. 3) in two weeks. Smaller,
thinner crystals were obtained in many of the other drops.
The crystals were fragile and needed careful manipulation during
harvesting, derivatization and soaking with cryoprotectant solution,
which could only be successfully performed in the same drop that the
crystals had grown in. Transfer of a crystal from the drop to another
solution always led to visible degradation and loss of diffraction
properties. Several data sets were collected; well harvested crystals
generally diffracted to high resolution, but often showed high
mosaicity and/or multiple lattices, making indexing and/or integration
impossible. However, we were successful in collecting both a
reasonable native and derivative data set from two independent
crystals.
The best native crystal diffracted to a resolution of at least 1.8 A˚
and belonged to the P1 triclinic space group. The crystals are most
likely to have four molecules of protein per unit cell and a solvent
content of 48% (Matthews coefficient of 2.3 A˚3 Da1; Matthews,
1968). In the highest resolution shell, the merging R factor is still
reasonable and the signal-to-noise ratio is still relatively high (Table
1). If the detector were to have been positioned closer, useful data to
somewhat higher resolution might have been obtained (Evans &
Murshudov, 2013). Unfortunately, owing to the low symmetry and the
low resulting multiplicity of the data, correlation coefficients between
half data sets could not be calculated. With hindsight, we would have
collected data corresponding to a total rotation range of 360 instead
of 180, but indexing of the first few images suggested a monoclinic
primitive lattice instead of a triclinic space group, on which the data-
collection strategy was based. Additional data may well also have
been of lower quality, as the crystal visibly suffered from radiation
damage after data collection.
When the protein sequence was compared against known struc-
tures in the Protein Data Bank, no highly similar sequences were
obtained. The top hit was the solution structure of the S. sapro-
phyticus CHAP domain solved by nuclear magnetic resonance
spectroscopy (PDB entry 2k3a; Rossi et al., 2009), with 26 identical
amino acids over a stretch of 94 residues (28%). Structure solution
attempts by molecular replacement using this model or less homo-
logous crystallographic models did not give positive results, and
therefore derivatization with methylmercury chloride was performed.
The methylmercury-derivative crystals diffracted to 1.7 A˚ resolu-
tion and belonged to the same P1 triclinic space group with virtually
identical unit-cell parameters. Data were collected at the mercury LI
edge, rather than at the LIII edge as intended, owing to misinter-
pretation of the remote data-collection interface. As a result, the data
contained limited anomalous signal; they were also rather incomplete
at high resolution owing to spot overlap (Table 1; up to 2.14 A˚
resolution, 96% of the data were present at 3.3-fold multiplicity).
Nevertheless, the derivative crystal structure could be solved after
careful data processing and automated phase determination using
single-wavelength anomalous dispersion (SAD). Seven potential
mercury sites were found; as the CHAPK protein contains one
cysteine residue (Cys54), four were expected. After automatic model
building, 619 residues in ten chains were present, clustered into four
independent globular protein molecules. If indeed four molecules are
present, 94% of the 660 expected residues have been automatically
built and docked into sequence. After the refinement included in the
automated procedure, values of 23.3 and 28.4% were obtained for
Rwork and Rfree, respectively. Full refinement of the native and deri-
vative structures, manual model adjustment and structure analysis
will be performed and will be reported elsewhere.
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Figure 2
Denaturing gel electrophoresis of purified protein used for crystallization. Low-
range molecular-weight markers, with the sizes indicated in kDa, were loaded in the
left lane. A sample of the purified protein was loaded in the right lane.
Figure 3
Crystals of the S. aureus bacteriophage K endolysin CHAP domain. Crystals grew
as clusters of thin, but sizable, plates from which single crystals could be separated
by careful manipulation. The size of the scale bar is around 0.5 mm.
On the basis of the structure, it should be possible to formulate
hypotheses about the reaction mechanism, which could then be tested
by site-directed mutation and biochemical methods. This knowledge,
in turn, might lead to recombinant enzymes with an improved
exolysis mechanism or different pathogen specificities.
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Table 1
Crystallographic data collection.
Values in parentheses are for the highest resolution bin. ND: not determined (see text).
Native Methylmercury
derivative
Synchrotron, beamline ESRF, ID23-2 DLS, I02
Detector MarMOSAIC PILATUS 6M
Crystal-to-detector
distance (mm)
170 529
Wavelength (A˚) 0.8726 0.8352
No. of images 180 900
Oscillation range () 1.0 0.4
Unit-cell parameters (A˚, ) a = 39.2, b = 61.5,
c = 73.1,  = 91.5,
 = 98.6,  = 90.0
a = 39.0, b = 61.5,
c = 72.8,  = 91.8,
 = 98.7,  = 90.0
Resolution range (A˚) 36.53–1.79 (1.88–1.79) 71.92–1.71 (1.76–1.71)
Reflections 62028 (8788) 48498 (572)
Multiplicity 2.0 (1.9) 3.4 (3.2)
Completeness (%) 97.2 (94.3) 64.7 (10.4)
Mean I/(I) 6.3 (2.9) 11.8 (1.8)
Rmerge† (%) 9.1 (25.1) 6.0 (62.0)
CC Imean ND 0.994 (0.666)
CC anom ND 0.354 (0.001)
Wilson B (A˚2) 14.5 14.9
Phasing
Correlation coefficient (all/weak) 37.79/22.57
Patterson figure of merit 53.52
Correlation coefficient (E) 0.328
RCullis (anomalous) 0.853
Anomalous phasing power 0.888
Figure of merit 0.305
Solvent flattening (45.6% solvent)
Final correlation on |E|2/contrast 2.2122
Hand score = correlation on
|E|2/contrast (original/inverted)
0.3245/0.2371
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ where Ii(hkl) is the intensity of
the ith measurement of the same reflection and hI(hkl)i is the mean observed intensity for
that reflection.
